GSK plc (GSK)

NYQ – Real vaqt narxi. Valyuta: USD

52.50

+0.61 (1.18%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

52.51

+0.01 (0.03%)

Bozordan keyin: Jun 26, 2026, 7:29 PM EDT

12.06.2026

GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder

GSK's momelotinib wins FDA and EMA orphan status for VEXAS syndrome, backed by early evidence. The company advances a phase II/III study.

11.06.2026

Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines

Pharma and biotech dealmaking is surging in 2026 as companies pursue acquisitions to expand pipelines, strengthen portfolios and drive growth.

11.06.2026

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

The sudden $10.6 billion acquisition of Nuvalent NASDAQ: NUVL by GSK NYSE: GSK violently shatters a lingering mergers and acquisitions (M&A) drought across the mid-cap biotechnology sector.

11.06.2026

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

GSK's record $10.6 billion deal for U.S. company Nuvalent will accelerate the British drugmaker's rebuild of its cancer drug business as it seeks to fend off competition from bigger rivals AstraZeneca and Roche.

10.06.2026

GSK plc (GSK) M&A Call Transcript

10.06.2026

Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Nuvalent, Inc. (NasdaqGS: NUVL) to GSK plc (NYSE: GSK). Under the terms of the proposed transaction, shareholders of Nuvalent will receive $124.00 in cash for each share of Nuvalent that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or.

10.06.2026

GSK's Nuvalent deal tackles HIV cliff to win cautious backing from analysts

GSK PLC's (LSE:GSK, NYSE:GSK) $10.6 billion (£8bn) acquisition of US biotech Nuvalent has achieved something unusual in large pharmaceutical M&A: analysts broadly agree it makes sense. The debate is less about whether the deal is strategically sound and more about how much upside remains after shelling out a chunky amount for two relatively mature assets.

Videolar

09.06.2026

Positive

Tuesday's Morning Movers: MU Rebounds, ON PT Increases & GSK Buys NUVL

05.02.2026

Positive

3 International Stocks to Buy for 2026

01.12.2025

Neutral

BREAKING: Trump strikes major deal with UK on drug pricing

04.11.2025

Neutral

3 Dividend Stocks for November 2025

Press-relizlar

10.06.2026

Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL

08.06.2026

Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression

Collaboration leverages Engitix's human ECM Platform to identify high-confidence targets for liver fibrosis regression Collaboration leverages Engitix's human ECM Platform to identify high-confidence targets for liver fibrosis regression

07.05.2026

Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults

PHILADELPHIA--(BUSINESS WIRE)-- #Adolescents--Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults.

31.03.2026

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishes its first U.S. manufacturing presence, expanding regional client support Plans further investments to add capabilities and strengthen long-term operations at the Rockville site INCHEON, South Korea and ROCKVILLE, MD., March 31, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company's first manufacturing presence in the United States.

GSK plc (GSK)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

GSK plc (GSK)

GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder

Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion